Resumen del episodio
Not all body fat behaves the same way. While subcutaneous fat simply stores energy beneath the skin, deep visceral fat acts like a metabolically active organ—wrapping around vital organs and disrupting normal inflammatory and insulin signaling. In this episode of the PeptideResearch.us Podcast, Amy Andrews and Todd Collins—the AI personas of PeptideResearch.us—unpack the science behind Tesamorelin, a synthetic analog of Growth Hormone Releasing Hormone (GHRH). Breaking down complex endocrinol...
Not all body fat behaves the same way. While subcutaneous fat simply stores energy beneath the skin, deep visceral fat acts like a metabolically active organ—wrapping around vital organs and disrupting normal inflammatory and insulin signaling. In this episode of the PeptideResearch.us Podcast, Amy Andrews and Todd Collins—the AI personas of PeptideResearch.us—unpack the science behind Tesamorelin, a synthetic analog of Growth Hormone Releasing Hormone (GHRH). Breaking down complex endocrinol...
Episodios
How Does Tesamorelin Reduce Visceral Fat?
EscuchadoNot all body fat behaves the same way. While subcutaneous fat simply stores energy beneath the skin, deep visceral fat acts like a metabolically active organ—wrapping around vital organs and disrupting normal inflammatory and insulin signaling. In this episode of the PeptideResearch.us Podcast, Amy Andrews and Todd Collins—the AI personas of PeptideResearch.us—unpack the science behind Tesamorelin, a synthetic analog of Growth Hormone Releasing Hormone (GHRH). Breaking down complex endocrinol...
Retatrutide vs. Semaglutide: Breaking Down the October 2026 Head-to-Head Trial Results
EscuchadoIn this episode of the PeptideResearch.us Podcast, hosts Amy Andrews and Todd Collins unpack the October 2026 topline results from the Phase 3 TRANSCEND-T2D-2 trial—the first head-to-head study directly comparing retatrutide and semaglutide over 80 weeks. Semaglutide has long served as the benchmark for single-pathway GLP-1 research, while retatrutide introduces a triple-hormone receptor approach targeting GLP-1, GIP, and glucagon receptors simultaneously. Amy and Todd (AI voices of Pep...
BPC-157, TB-500, and the Wolverine Stack: Single Peptides vs. Combined Compounds Explained
EscuchadoWhy do researchers frequently group BPC-157 and TB-500 together under the nickname "the Wolverine stack"—and how do scientists decide between studying one peptide, using both separately, or working with a combined compound? In this episode of the PeptideResearch.us Podcast, host Amy Andrews and research educator Todd Collins break down the fascinating cellular science behind two of the most talked-about recovery peptides in modern research. You'll learn how BPC-157 supports angiogenesis to cl...
Overcoming Tirzepatide and Retatrutide Weight Loss Plateaus
EscuchadoClick here to join our Discord: Real Peptide Talk Shop Research Compounds: https://wholesalepeptides.us Visit our blog: https://peptideresearch.us Join our Newsletter list: https://peptideresearch.us/newsletter Affiliate Program: https://wholesalepeptides.us/affiliate-registration-2/ In this episode of the PeptideResearch.us Podcast, hosts Amy Andrews and Todd Collins (AI personas of Peptide Research) examine the inferential gap between group-level trial statistics and individual outcomes, ...
Retatrutide vs Semaglutide: October 2026 Trial Results
EscuchadoClick here to join our Discord: Real Peptide Talk Shop Research Compounds: https://wholesalepeptides.us Visit our blog: https://peptideresearch.us Join our Newsletter list: https://peptideresearch.us/newsletter Affiliate Program: https://wholesalepeptides.us/affiliate-registration-2/ In this episode of the PeptideResearch.us Podcast, hosts Amy Andrews and Todd Collins (AI personas of Peptide Research) examine comparative trial design, the methodological difference between a direct randomize...